Zoetic International PLC is a reputable company that upholds strong values and embodies a progressive corporate philosophy. Committed to innovation and sustainability, Zoetic International PLC aims to provide quality products and services while prioritizing social and environmental responsibility. With a focus on efficient operations and ethical practices, the company strives for long-term growth and success. Zoetic International PLC's dedication to transparency, integrity, and customer satisfaction sets it apart in the market. By consistently delivering value and embracing a forward-thinking approach, Zoetic International PLC continues to build trust and drive positive change in its industry.

Zoetic International PLC is primarily present in various countries and regions around the world. The company's global presence spans across the United States, United Kingdom, Europe, and Australia, among others. With its diverse operations, Zoetic International PLC has successfully expanded its footprint in key international markets.

Zoetic International PLC has achieved several significant milestones. The company successfully expanded its product portfolio and entered the CBD and hemp market with a range of wellness and skincare products. Zoetic International PLC also established strategic partnerships with leading retailers, broadening its distribution network. Furthermore, the company has made advancements in sustainable farming practices, emphasizing environmentally friendly cultivation methods. Additionally, Zoetic International PLC has shown strong financial growth, reporting increased revenue and profitability in recent years. Overall, the company's milestones reflect its commitment to innovation, market expansion, and sustainable business practices.

Zoetic International PLC, established in 2019, is a globally operating CBD biotechnology company. With headquarters in the United Kingdom, the company focuses on the production and distribution of high-quality cannabidiol (CBD) products. Zoetic International PLC possesses a strong commitment to sustainable agricultural practices, ensuring the utilization of ethically grown hemp plants. By leveraging advanced extraction techniques, the company transforms these plants into premium CBD products that cater to various consumer needs. With a customer-centric approach and emphasis on innovation, Zoetic International PLC aims to expand its market presence and provide individuals worldwide with the therapeutic benefits of CBD.

The main competitors of Zoetic International PLC in the market are [competitor 1], [competitor 2], and [competitor 3]. These companies operate in the same industry as Zoetic International PLC and offer similar products or services. However, Zoetic International PLC differentiates itself through its [unique selling point or competitive advantage]. By continually striving to innovate and deliver superior products, Zoetic International PLC aims to remain a top player in the market.

Zoetic International PLC is primarily active in two industries: CBD and medicinal cannabis. As a leading company in these sectors, Zoetic International PLC specializes in the production, research, and development of high-quality CBD products, including oils, vape liquids, and skincare. Furthermore, the company has ventured into the cultivation and distribution of medicinal cannabis, focusing on therapeutically beneficial strains. With its strong presence in the CBD and medicinal cannabis industries, Zoetic International PLC is dedicated to providing innovative and sustainable solutions, ensuring the highest standards of product quality and consumer satisfaction.

The business model of Zoetic International PLC involves the innovative production and distribution of high-quality cannabidiol (CBD) products globally. Zoetic International PLC focuses on cultivating hemp plants with high CBD content, ensuring superior quality as the key differentiator. This vertically integrated company manages the entire value chain, from seed to sale, providing full traceability and quality control. Zoetic International PLC capitalizes on the growing popularity of CBD products, which are known for their potential health and wellness benefits. The company's commitment to quality, eco-friendly practices, and customer satisfaction drives its success in the CBD market.

Aktuálny KGV pre Chill Brands Group sa nedá vypočítať.

Aktuálne nie je možné vypočítať KUV pre Chill Brands Group.

AlleAktien kvalitatívne skóre pre Chill Brands Group je 2/10.

Aktuálne nie je možné vypočítať obrat pre Chill Brands Group.

Zisk momentálne nie je možné vypočítať pre Chill Brands Group.

Zoetic International PLC is a rapidly growing company specializing in the production and marketing of CBD products in the health and wellness sector. The company utilizes its extensive knowledge in hemp production and processing to deliver top-quality CBD products. The business model of Zoetic International PLC consists of three main divisions: hemp cultivation and processing, CBD product manufacturing, and sales and marketing. Hemp cultivation and processing are carried out in close collaboration with farmers and producer communities specialized in hemp production. The company exclusively uses organic farming methods and does not use chemical pesticides or herbicides to guarantee the high quality standard of its products. The production of CBD products takes place in specialized facilities operated according to the highest industry standards. Zoetic International PLC produces a wide range of CBD products, including oils, capsules, creams, and vaping products, all made from high-quality raw materials. The company uses both broad-spectrum and isolated CBD extracts to cater to different applications. The company also has an in-house marketing and sales team that promotes and distributes its products through various channels, including retail, online sales, and B2B transactions. Zoetic International PLC collaborates with partners worldwide to bring its products to global markets. The company has also specialized in the production of CBD for the growing market of animal health. Zoetic International offers a wide range of CBD products for animals that help alleviate conditions such as anxiety disorders, joint pain, and neurological diseases. The core objective of Zoetic International is to provide the highest quality of its products for effective treatment of health issues while also offering customers a premium experience with their products. Overall, Zoetic International has established a promising and scalable business model focusing on providing high-quality, natural, and effective CBD products. The diversification of its offerings into various markets, including animal health, combined with a strong marketing and sales network, positions the company for a sustainable future with high growth potential.

Chill Brands Group vypláca dividendu vo výške 0 GBP rozdelenú do výplat počas roka.

Dividenda pre Chill Brands Group sa aktuálne nedá vypočítať alebo spoločnosť nevypláca dividendu.

ISIN spoločnosti Chill Brands Group je GB00BWC4X262.

WKN spoločnosti Chill Brands Group je A14Q02.

Ticker spoločnosti Chill Brands Group je CHLL.L.

V posledných 12 mesiacoch spoločnosť Chill Brands Group vyplatila dividendu vo výške . To zodpovedá dividendovému výnosu približne . Pre nadchádzajúcich 12 mesiacov bude pravdepodobne spoločnosť Chill Brands Group vyplácať dividendu 0 GBP.

Súčasný výnos z dividend spoločnosti Chill Brands Group je .

Chill Brands Group vypláca dividendu každý štvrťrok. Tá je vyplácaná v mesiacoch .

Chill Brands Group platil každý rok počas posledných 0 rokov dividendu.

Na nasledujúcich 12 mesiacov sa očakávajú dividendy vo výške 0 GBP. To zodpovedá dividendovému výnosu 0 %.

Chill Brands Group je priradený sektoru 'Energia'.

Aby ste obdržali poslednú dividendu vo výške 0 GBP od Chill Brands Group z dňa 21. 7. 2024, museli ste mať akciu v depozite pred ex-dňom 21. 7. 2024.

Posledná dividenda bola vyplatená 21. 7. 2024.

V roku 2023 boli od Chill Brands Group 0 GBP vyplatené ako dividendy.

Dividendy spoločnosti Chill Brands Group sú vyplácané v GBP.